Long-term doxazosin therapy in diabetic hypertension

R. Fogari, A. Zoppi, P. Lazzari, F. Tettamanti, G. D. Malamani, A. Mugellini, M. Da Busti, L. Corradi

Research output: Contribution to journalArticle


Few studies have assessed the long-term efficacy and metabolic effects doxazosin, a selective alpha1 -adrenoceptor antagonist, in the treatment of hypertension in non-insulin dependent diabetes mellitus (NIDDM). Twenty middle-aged males (43 to 69 years old) with mild hypertension (DBP≥95 and

Original languageEnglish
Pages (from-to)145-150
Number of pages6
JournalJournal of Drug Development
Issue number3
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Long-term doxazosin therapy in diabetic hypertension'. Together they form a unique fingerprint.

  • Cite this

    Fogari, R., Zoppi, A., Lazzari, P., Tettamanti, F., Malamani, G. D., Mugellini, A., Da Busti, M., & Corradi, L. (1991). Long-term doxazosin therapy in diabetic hypertension. Journal of Drug Development, 4(3), 145-150.